Download PDF
Nuklearmedizin 1995; 34(01): 61-67
DOI: 10.1055/s-0038-1629693
Original Article
Schattauer GmbH

Die Thalliumszintigraphie des Myokards

Einheitliches Untersuchungsprotokoll der Österreichischen Gesellschaft für Nuklearmedizin
H. Fritzsche
,
H. Bergmann
,
L. Fridrich
,
H. Köhn
,
P. Lind
,
J. Mlczoch
,
A. Mostbeck
,
G. Porenta
Further Information

Publication History

Publication Date:
04 February 2018 (online)

    Permissions and Reprints

Zusammenfassung

Zur Vermeidung von Interpretationsschwierigkeiten der verschiedenen Untersuchungsprotokolle und von Wiederholungsuntersuchungen der Thalliumszintigraphie des Myokards wurde ein für Österreich einheitliches Untersuchungsprotokoll erarbeitet. Ab 1.1. 1995 wird dieses Untersuchungsprotokoll zum Einsatz kommen, Abweichungen von diesem Protokoll müssen besonders vermerkt werden. Es werden der Untersuchungablauf, die Belastungsmethoden mit dem Ergometer und mit pharmakologischen Substanzen, die Aufnahmetechnik der planaren und SPECT-Szintigraphie, die Auswertemethoden und die Qualitätskontrolle der Geräte festgelegt.

Summary

A uniform protocol for thallium scintigraphy of the myocardium has been issued in Austria to avoid difficulties in interpreting results and to avoid repeated examinations to save expenses and radiation burden. From the beginning of 1995 this protocol will be used in the Austrian departments of Nuclear Medicine, differences from this protocol have to be mentioned separately. In this protocol the procedure of examination. bicycle and pharmacological stress testing and vasodilatation, acquisition techniques for planar and SPECT imaging, data processing and quality control of devices are defined.

 

  • Allgemein

  • 1 Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med 1979; 300: 1350-8.
    CrossrefPubMedGoogle Scholar
  • 2 Maddahi J, Garcia EV, Berman DS, Waxman A, Swan HJC, Forrester J. Improved noninvasive assessment of coronary artery disease by quantitative analysis of regional stress myocardial distribution and washout of thallium-201. Circulation 1981; 64: 924-35.
    CrossrefPubMedGoogle Scholar
  • 3 Garcia EV, Van Train K, Maddahi J, Prigent F, Areeda J, Waxman A, Berman DS. Quantification of rotational thallium-201 myocardial tomography. J Nucl Med 1985; 26: 17-26.
    PubMedGoogle Scholar
  • 4 Maddahi J, Van Train EK, Prigent F, Garcia EV, Friedman J, Ostrzega E, Berman D. Quantitative single photon emission computerized thallium-201 tomography for detecting and localization of coronary artery disease: Optimization and prospective validation of a new technique. J Am Coll Cardiol 1989; 14: 1689-99.
    CrossrefPubMedGoogle Scholar
  • 5 Fintel DJ, Links JM, Brinker JA, Frank TL, Parker M, Becker LC. Improved diagnostic performance of exercise thallium-201 single photon emission computed tomography over planar imaging in the diagnosis of coronary artery disease: A receiver operating characteristic analysis. J Am Coll Cardiol 1989; 13: 600-12.
    CrossrefPubMedGoogle Scholar
  • 6 Kaul S. A look at 15 years of planar thallium-201 imaging. Am Heart J 1989; 118 (Suppl. 03) 581-601.
    CrossrefPubMedGoogle Scholar
  • 7 DePuey GE, Garcia EV. Optimal specificity of thallium-201 SPECT through recognition of imaging artefacts. J Nucl Med 1989; 30: 441-9.
    PubMedGoogle Scholar
  • 8 Standardizationofcardiac tomographic imaging. J Am Coll Cardiol 1992; 20: 255-6.
    CrossrefPubMedGoogle Scholar
  • 9 Zaret BL, Wackers FJ. Nuclear cardiology. N Engl J Med 1993; 329 (Suppl. 11) 775-83.
    CrossrefPubMedGoogle Scholar
  • 10 Beller GA. Myocardial perfusion imaging with thallium-201. J Nucl Med 1994; 35 (Suppl. 04) 674-80.
    PubMedGoogle Scholar
  • 11 Penneil DJ, Underwood SR, Swanton RH, Walker JM, Ell PJ. Dobutamine thallium myocardial perfusion tomography. J Am Coll Cardiol 1991; 18 (Suppl. 06) 1471-9.
    CrossrefPubMedGoogle Scholar
  • 12 Hays JT, Mahmarian JJ, Cochran AJ, Verani MS. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol 1993; 21 (Suppl. 07) 1583-90.
    CrossrefPubMedGoogle Scholar
  • 13 Penneil DJ, Underwood SR, Ell PJ. Safety of dobutamine stress for thallium-201 myocardial perfusion tomography in patients with asthma. Am J Cardiol 1993; 71 (Suppl. 15) 1346-50.
    CrossrefPubMedGoogle Scholar
  • 14 Verani MS. Dobutamine myocardial perfusion imaging. J Nucl Med 1994; 34 (Suppl. 05) 737-9.
    Google Scholar
  • 15 Varma SK, Watson DD, Beller GA. Quantitative comparison of thallium-201 scintigraphy after exercise and dipyridamole in coronary artery disease. Am J Cardiol 1989; 64: 871-7.
    CrossrefPubMedGoogle Scholar
  • 16 Leppo JA. Dipyridamole-thallium imaging: the lazy man’s stress test. J Nucl Med 1989; 30 (Suppl. 03) 281-7.
    PubMedGoogle Scholar
  • 17 Lette J. Safety of dipyridamole testing: preliminary results in 43,000 patients [Abstract]. J Am Coll Cardiol 1993; 21: 207A.
    Google Scholar
  • 18 Leppo JA. Dipyridamole myocardial perfusion imaging. J Nucl Med 1994; 35 (Suppl. 04) 730-3.
    PubMedGoogle Scholar
  • 19 Verani MS. Pharmacological stress with adenosine for myocardial perfusion imaging. Semin Nucl Med 1991; 21 (Suppl. 03) 266-72.
    CrossrefPubMedGoogle Scholar
  • 20 Abreu A, Mahmarian JJ, Nishimura S, Boyce TM, Verani MS. Tolerance and safety of pharmacologic coronary vasodilation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery disease. J Am Coll Cardiol 1991; 18 (Suppl. 03) 730-5.
    CrossrefPubMedGoogle Scholar
  • 21 Nishimura S, Mahmarian JJ, Boyce TM, Verani MS. Equivalence between adenosine and exercise thallium-201 myocardial tomography: a multicenter, prospective, crossover trial. J Am Coll Cardiol 1992; 20 (Suppl. 02) 265-75.
    CrossrefPubMedGoogle Scholar
  • 22 Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging in 9,256 patients: results from the Adenoscan multicenter trial registry. J Am Coll Cardiol 1994; 23: 384-9.
    CrossrefPubMedGoogle Scholar
  • 23 Iskandrian AS. Adenosine myocardial perfusion imaging. J Nucl Med 1994; 35 (Suppl. 04) 734-6.
    PubMedGoogle Scholar
  • 24 Dilsizian V, Rocco TP, Freedman MN, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323: 141-6.
    CrossrefPubMedGoogle Scholar
  • 25 Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18 F-fluorodeoxyglucose. Circulation 1991; 83 (Suppl. 01) 26-37.
    Google Scholar
  • 26 Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993; 87 (Suppl. 01) 1-20.
    CrossrefPubMedGoogle Scholar
  • 27 Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution 201T1 imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993; 87 (Suppl. 05) 1630-41.
    CrossrefPubMedGoogle Scholar
  • 28 Udelson JE, Coleman PS, Metherall J, Pandian NG, Gomez AR, Griffith JL, Shea NL, Oates E, Konstam MA. Predicting recovery of severe regional ventricular dysfunction: comparison of resting scintigraphy with 20,TI and WmTc-Sestamibi. Circulation 1994; 89 (Suppl. 06) 2552-61.
    CrossrefPubMedGoogle Scholar